Evidence map›Paper›PMID 34284785›Full record

ArticleBMC health services research2021

Continuous quality improvement (CQI) Institutionalization to reach 95:95:95 HIV targets: a multicountry experience from the Global South.

Peter Memiah, Josephine Tlale, Mope Shimabale, Sarah Nzyoka, Patience Komba, Jackson Sebeza, Adesina Tina, Violet Makokha

Abstract read
In one paragraph

Article in BMC health services research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Peter MemiahDivision of Epidemiology and Prevention, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Room N345, MD, 21201, Baltimore, USA. pmemiah@ihv.umaryland.edu.
Josephine TlaleInstitute of Human Virology, Center for International Health, Education, and Biosecurity (CIHEB), University of Maryland School of Medicine in Botswana, Gaborone, Botswana.
Mope ShimabaleInstitute of Human Virology, Center for International Health, Education, and Biosecurity (CIHEB), University of Maryland School of Medicine in Zambia, Lusaka, Zambia.
Sarah NzyokaInstitute of Human Virology, Center for International Health, Education, and Biosecurity (CIHEB), University of Maryland School of Medicine in Kenya, Baltimore, Kenya.
Patience KombaInstitute of Human Virology, Center for International Health, Education, and Biosecurity (CIHEB), University of Maryland School of Medicine in Tanzania, Baltimore, Tanzania.
Jackson SebezaInstitute of Human Virology, Center for International Health, Education, and Biosecurity (CIHEB), University of Maryland School of Medicine in Rwanda, Kigali, Rwanda.
Adesina TinaInstitute of Human Virology, Center for International Health, Education, and Biosecurity (CIHEB), University of Maryland School of Medicine in Nigeria, Abuja, Nigeria.
Violet MakokhaInstitute of Human Virology, Center for International Health, Education, and Biosecurity (CIHEB), University of Maryland School of Medicine in Kenya, Baltimore, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScaling up continuous quality improvement (CQI) processes could be key in achieving the 95:95:95 cascade and global HIV targets. This paper describes the experiences and outcomes related to implementing CQI processes to help reach these targets, with particular focus on clinical and programmatic settings in 6 countries from the global south.

methodsThe HIV program at the University of Maryland, Baltimore (UMB) implemented an adapted CQI model in Kenya, Tanzania, Botswana, Zambia, Nigeria and Rwanda that included the following steps: (1) analysing the problem to identify goals and objectives for improvement; (2) developing individual changes or 'change packages', (3) developing a monitoring system to measure improvements; and (4) implementing and measuring changes through continuous 'plan-do-study-act' (PDSA) cycles. We describe country-level experiences related to implementing this adaptive design, a collaborative learning and scale-up/sustainability model that addresses the 95:95:95 global HIV targets via a CQI learning network, and mechanisms for fostering communication and the sharing of ideas and results; we describe trends both before and after model implementation.

resultsOur selected country-level experiences based on implementing our CQI approach resulted in an increased partner testing acceptance rate from 21.7 to 48.2 % in Rwanda, which resulted in an increase in the HIV testing yield from 2.1 to 6.3 %. In Botswana, the overall linkage to treatment improved from 63 to 94 %, while in Kenya, the viral load testing uptake among paediatric and adolescent patients improved from 65 to 96 %, and the viral load suppression improved from 53 to 88 %.

conclusionsAdopting CQI processes is a useful approach for accelerating progress towards the attainment of the global 95:95:95 HIV targets. This paper also highlights the value of institutionalizing CQI processes and building the capacity of Ministry of Health (MoH) personnel in sub-Saharan Africa for the effective quality improvement of HIV programs and subsequent sustainability efforts.

Indexed as

HIV InfectionsQuality ImprovementAdolescentBaltimoreBotswanaChildHumansInstitutionalizationKenyaNigeriaRwandaTanzaniaZambiaHealth SystemsHIVQuality ImprovementSustainability

Identifiers

PMID34284785
PMCPMC8293523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.